Europe RNA Analysis Market Size, Share & Industry Trends Analysis Report By Product, By Technology (Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology), By End-use, By Application, By Country and Growth Forecast, 2022 - 2028
The Europe RNA Analysis Market would witness market growth of 15.1% CAGR during the forecast period (2022-2028).
Long noncoding RNAs are a prominent subclass of ncRNAs. During the extensive sequencing of cDNA libraries, lncRNAs were first identified as a functional class and first reported in mice. LncRNAs have been implicated in a wide range of molecular processes, including chromatin remodeling, transcriptional regulation, and posttranscriptional processing, albeit the bulk of these is still poorly understood.
Analysis of RNA transcripts using next-generation sequencing techniques, which need RNA to be translated into complementary DNA before sequencing, is known as RNA. It uses a variety of methods, including q PCR and microarrays. The most popular method utilized in research labs is microarray technology. It is called quantitative reverse transcription (q PCR) and is carried out using the polymerase chain reaction. Q PCR is used to identify the presence and quantity of RNA by converting it into cDNA.
The health technology sector can be led by the United Kingdom. They already have some of the most successful health technology companies in the world, which contribute to innovative innovations and improve the country's reputation abroad as a strong scientific and research base. Additionally, it has the potential to create an ecosystem that consistently generates the best transferable health-tech as well as cutting-edge approaches and insights that can enhance health outcomes.
The Germany market dominated the Europe RNA Analysis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,863.5 million by 2028. The UK market is experiencing a CAGR of 14.1% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 16% during (2022 - 2028).
Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology and Others. Based on End-use, the market is segmented into Government Institutes & Academic Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROs). Based on Application, the market is segmented into Infectious Diseases & Pathogenesis, Epigenetics, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics, Construction of RNA Expression Atlas, Alternative RNA Splicing and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, Merck Group, and Promega Corporation.
Scope of the Study
Market Segments covered in the Report:
By Product
- Kits & Reagents
- Instruments
- Services
- Real Time-PCR (qPCR) Technology
- Sequencing Technology
- Microarray Technology
- Others
- Government Institutes & Academic Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Infectious Diseases & Pathogenesis
- Epigenetics
- RNA Structure & Molecular Dynamics
- Development & Delivery of RNA Therapeutics
- Construction of RNA Expression Atlas
- Alternative RNA Splicing
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific Group
- Merck Group
- Promega Corporation
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe RNA Analysis Market, by Product
- 1.4.2 Europe RNA Analysis Market, by Technology
- 1.4.3 Europe RNA Analysis Market, by End-use
- 1.4.4 Europe RNA Analysis Market, by Application
- 1.4.5 Europe RNA Analysis Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition & scenarios
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Geographical Expansions
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players
- Chapter 4. Europe RNA Analysis Market by Product
- 4.1 Europe Kits & Reagents Market by Country
- 4.2 Europe Instruments Market by Country
- 4.3 Europe Services Market by Country
- Chapter 5. Europe RNA Analysis Market by Technology
- 5.1 Europe Real Time-PCR (qPCR) Technology Market by Country
- 5.2 Europe Sequencing Technology Market by Country
- 5.3 Europe Microarray Technology Market by Country
- 5.4 Europe Others Market by Country
- Chapter 6. Europe RNA Analysis Market by End-use
- 6.1 Europe Government Institutes & Academic Centers Market by Country
- 6.2 Europe Hospitals & Clinics Market by Country
- 6.3 Europe Pharmaceutical & Biotechnology Companies Market by Country
- 6.4 Europe Contract Research Organizations (CROs) Market by Country
- Chapter 7. Europe RNA Analysis Market by Application
- 7.1 Europe Infectious Diseases & Pathogenesis Market by Country
- 7.2 Europe Epigenetics Market by Country
- 7.3 Europe RNA Structure & Molecular Dynamics Market by Country
- 7.4 Europe Development & Delivery of RNA Therapeutics Market by Country
- 7.5 Europe Construction of RNA Expression Atlas Market by Country
- 7.6 Europe Alternative RNA Splicing Market by Country
- 7.7 Europe Others Market by Country
- Chapter 8. Europe RNA Analysis Market by Country
- 8.1 Germany RNA Analysis Market
- 8.1.1 Germany RNA Analysis Market by Product
- 8.1.2 Germany RNA Analysis Market by Technology
- 8.1.3 Germany RNA Analysis Market by End-use
- 8.1.4 Germany RNA Analysis Market by Application
- 8.2 UK RNA Analysis Market
- 8.2.1 UK RNA Analysis Market by Product
- 8.2.2 UK RNA Analysis Market by Technology
- 8.2.3 UK RNA Analysis Market by End-use
- 8.2.4 UK RNA Analysis Market by Application
- 8.3 France RNA Analysis Market
- 8.3.1 France RNA Analysis Market by Product
- 8.3.2 France RNA Analysis Market by Technology
- 8.3.3 France RNA Analysis Market by End-use
- 8.3.4 France RNA Analysis Market by Application
- 8.4 Russia RNA Analysis Market
- 8.4.1 Russia RNA Analysis Market by Product
- 8.4.2 Russia RNA Analysis Market by Technology
- 8.4.3 Russia RNA Analysis Market by End-use
- 8.4.4 Russia RNA Analysis Market by Application
- 8.5 Spain RNA Analysis Market
- 8.5.1 Spain RNA Analysis Market by Product
- 8.5.2 Spain RNA Analysis Market by Technology
- 8.5.3 Spain RNA Analysis Market by End-use
- 8.5.4 Spain RNA Analysis Market by Application
- 8.6 Italy RNA Analysis Market
- 8.6.1 Italy RNA Analysis Market by Product
- 8.6.2 Italy RNA Analysis Market by Technology
- 8.6.3 Italy RNA Analysis Market by End-use
- 8.6.4 Italy RNA Analysis Market by Application
- 8.7 Rest of Europe RNA Analysis Market
- 8.7.1 Rest of Europe RNA Analysis Market by Product
- 8.7.2 Rest of Europe RNA Analysis Market by Technology
- 8.7.3 Rest of Europe RNA Analysis Market by End-use
- 8.7.4 Rest of Europe RNA Analysis Market by Application
- Chapter 9. Company Profiles
- 9.1 F. Hoffmann-La Roche Ltd.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Acquisition and Mergers:
- 9.2 Danaher Corporation
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Acquisition and Mergers:
- 9.3 Agilent Technologies, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.5.2 Product Launches and Product Expansions:
- 9.3.5.3 Acquisition and Mergers:
- 9.4 Thermo Fisher Scientific, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.5.2 Product Launches and Product Expansions:
- 9.4.5.3 Acquisition and Mergers:
- 9.5 Qiagen N.V.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Partnerships, Collaborations, and Agreements:
- 9.5.5.2 Product Launches and Product Expansions:
- 9.6 Illumina, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.5.2 Product Launches and Product Expansions:
- 9.6.5.3 Acquisition and Mergers:
- 9.7 Bio-Rad laboratories, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Product Launches and Product Expansions:
- 9.8 Eurofins Scientific Group
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Recent strategies and developments:
- 9.8.4.1 Product Launches and Product Expansions:
- 9.9 Merck Group
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.5.2 Acquisition and Mergers:
- 9.10. Promega Corporation
- 9.10.1 Company Overview
- 9.10.2 Recent strategies and developments:
- 9.10.2.1 Product Launches and Product Expansions:
- 9.10.2.2 Geographical Expansions:
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook